site stats

Impact factor jama oncol

Witryna5 lip 2024 · Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. ...  JAMA Oncol. 2024;5(10):e191870. doi: ... Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey. WitrynaNowotwory J Oncol znajdują się także — toutes proportions gardées — wśród instytucjonalnych, a ich redaktor — wśród indywidualnych sygnatariuszy Deklaracji. ... The history and meaning of the journal impact factor. JAMA 2006; 295: 90–93. Grant B. New impact factors yield surprises.

JAMA Impact Factor 2024 - Journal Impact Factor

Witryna23 sty 2008 · Context Comorbidities may increase the negative effects of specific anticancer treatments such as androgen suppression therapy (AST).. Objectives To compare 6 months of AST and radiation therapy (RT) to RT alone and to assess the interaction between level of comorbidity and all-cause mortality.. Design, Setting, and … WitrynaJAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. ... three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Cites per ... small world isn\\u0027t it lyrics https://soundfn.com

Association of Prognostic Value of Primary Tumor Location in ... - JAMA

Witryna1 sie 2024 · JAMA Oncol. 2024 Aug 1;6(8):1210-1217. doi: ... These findings suggest that the total volume of sedentary behavior is a potential cancer mortality risk factor and support the public health message that adults should sit less and move more to promote longevity. MeSH terms WitrynaJAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and … Witryna23 mar 2024 · 子宫腺肌症介绍,子宫腺肌症治疗方式,子宫腺肌症日常注意事项,壹大家好,今天和大家分享一篇发表在医学杂志JAMA上关于子宫腺肌症的临床更新。这篇临床更新总结了子宫腺肌症的诊断和管理,并提供了建议的治疗方法。概述子宫腺肌症是一种以子宫内膜腺体和基质出现在子宫肌层存 small world issues

About The Lancet Oncology

Category:Fatal Toxic Effects Associated With Immune Checkpoint ... - PubMed

Tags:Impact factor jama oncol

Impact factor jama oncol

JAMA Oncology - Wikipedia

Witryna11 kwi 2024 · 《gynecologic oncology》发布于爱科学网,并永久归类相关sci期刊导航类别中,本站只是硬性分析 "《gynecol oncol》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《gynecol oncol》" 的价值还取决于各种因素的综合分析。 WitrynaIt measures the number of times an average paper in a particular journal has been referred to elsewhere in scientific literature. The Impact Factor of journal J in the calendar year X is the number of citations received by J in X to any item published in J in (X-1) or (X-2), divided by the number of source items published in J in (X-1) or (X-2).

Impact factor jama oncol

Did you know?

WitrynaEffect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER … WitrynaThe journal’s impact factor of 24.8 places it as one of the highest-ranking oncology journals. Evaluating and selecting the best manuscripts for publication in the journal …

Witryna27 maj 2024 · JAMA Oncology Impact Score 2024-2024 The impact score (IS) 2024 of JAMA Oncology is 9.35, which is computed in 2024 as per its definition. JAMA … Witryna23 mar 2024 · JAMA Oncology—The Year in Review, 2024 Oncology JAMA Oncology JAMA Network This past year has been an exciting one for JAMA Oncology and its …

Witryna24 mar 2024 · Impact factor 3.467 (2024) Five year impact factor 23 days Submission to first decision (Median) 335,089 (2024) Downloads. Latest issue. Volume 28. Issue 4, April 2024 View all volumes and issues. Latest articles. The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of … WitrynaThis study aims to show that split-course therapy may achieve good local control tumor response rates at 6 months for those patients who are unfit to tolerate continuous therapy, and may be better tolerated, with decreased side effects. 103 Appropriate patient selection is critical, given that split-course therapy carries the potential risk of ...

WitrynaThe journal’s impact factor of 31.8 placed us as one of the highest-ranking oncology journals. Choosing the best articles for the journal was rewarding but challenging. We …

WitrynaJCO is one of the most prestigious oncology journals in the world, with an Impact Factor of 50.717, placing it among the top 1% of all journals, and with an Eigenfactor of 0.24903, which is the highest among oncology publications. In addition, JCO has the highest h-index among oncology journals reported by Google Scholar Metrics. small world italyWitrynaAnnals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review … hilary beard authorWitrynaThe impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of … hilary beason uabWitrynaJAMA Oncology's acceptance rate is 11% for research articles. The median time to first decision is 1 day, and 33 days with review. All major articles are published online first. … small world in disneylandWitryna12 kwi 2024 · Lymph node status is an important long-term prognostic factor for patients with iCCA. 32 Specifically, the presence of lymph node metastases not only adversely affects OS but also influences the relative effect of tumor number and vascular invasion on survival. 33 Therefore, assessment of the nodal basin should be performed at … small world jack stauber chordsWitryna1 gru 2024 · In the largest evaluation of fatal ICI-associated toxic effects published to date to our knowledge, we observed early onset of death with varied causes and … hilary beaver md ophthalmologyWitrynaThe Lancet Oncology is an internationally trusted source of clinical, public health, and global health knowledge. With an Impact Factor of 54·433, we are the world-leading clinical oncology research journal globally (2024 Journal Citation Reports ®, Clarivate 2024). We recognise that the Journal Impact Factor is just one measure of a journal ... small world japan